# OnCo record nct06075953 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06075953/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06075953", "NCT06075953" ;
  schema:name "DCIS RECAST"@en ;
  schema:alternateName "DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment"@en ;
  schema:description "RECAST tests whether hormone therapy and repeated scans can help identify people with ductal carcinoma in situ who can continue careful monitoring. Surgery is recommended if the study evaluations indicate it is needed."@en ;
  schema:url <https://onco.cc/trials/nct06075953/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06075953>, <https://clinicaltrials.ucsf.edu/trial/NCT06075953> ;
  onco:status "recruiting" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "2" ;
  schema:startDate "2024-02-17" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/elacestrant/>, <https://onco.cc/drugs/exemestane/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/tamoxifen/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .